Company Search:
Advanced Search
Sponsored Links
Anaptysbio Inc Company Snapshot
Anaptysbio Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anaptysbio Inc with three other companies in this sector in the United States: Intellia Therapeutics Inc (2016 sales of $16.48 million ), Egalet Corp ($16.96 million of which 100% was Pharmaceutical Preparations), and Urogen Pharma Ltd ($17.53 million of which 100% was Biopharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Anaptysbio Inc
  Stock Performance Chart for Anaptysbio Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 112.40
(Figures in U.S. Dollars)
1 Week 10.8%   13 Weeks 22.2%  
4 Weeks 61.6%   52 Weeks n/a  
Anaptysbio Inc Key Data:
  Ticker: ANAB Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 16,684,000
(Year Ending Jan 2017).
Employees: 49
  Currency: U.S. Dollars Market Cap: 2,617,785,547
  Fiscal Yr Ends: December Shares Outstanding: 23,289,907
  Share Type: Common Closely Held Shares: 388,937
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.